Table of Contents

2019-2024 Global Human Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Vaccine Consumption 2014-2024
2.1.2 Human Vaccine Consumption CAGR by Region
2.2 Human Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Rota vaccine
2.3 Human Vaccine Consumption by Type
2.3.1 Global Human Vaccine Consumption Market Share by Type (2014-2019)
2.3.2 Global Human Vaccine Revenue and Market Share by Type (2014-2019)
2.3.3 Global Human Vaccine Sale Price by Type (2014-2019)
2.4 Human Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccine Consumption by Application
2.5.1 Global Human Vaccine Consumption Market Share by Application (2014-2019)
2.5.2 Global Human Vaccine Value and Market Share by Application (2014-2019)
2.5.3 Global Human Vaccine Sale Price by Application (2014-2019)

3 Global Human Vaccine by Players
3.1 Global Human Vaccine Sales Market Share by Players
3.1.1 Global Human Vaccine Sales by Players (2017-2019)
3.1.2 Global Human Vaccine Sales Market Share by Players (2017-2019)
3.2 Global Human Vaccine Revenue Market Share by Players
3.2.1 Global Human Vaccine Revenue by Players (2017-2019)
3.2.2 Global Human Vaccine Revenue Market Share by Players (2017-2019)
3.3 Global Human Vaccine Sale Price by Players
3.4 Global Human Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Human Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Vaccine by Regions
4.1 Human Vaccine by Regions
4.1.1 Global Human Vaccine Consumption by Regions
4.1.2 Global Human Vaccine Value by Regions
4.2 Americas Human Vaccine Consumption Growth
4.3 APAC Human Vaccine Consumption Growth
4.4 Europe Human Vaccine Consumption Growth
4.5 Middle East & Africa Human Vaccine Consumption Growth

5 Americas
5.1 Americas Human Vaccine Consumption by Countries
5.1.1 Americas Human Vaccine Consumption by Countries (2014-2019)
5.1.2 Americas Human Vaccine Value by Countries (2014-2019)
5.2 Americas Human Vaccine Consumption by Type
5.3 Americas Human Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Vaccine Consumption by Countries
6.1.1 APAC Human Vaccine Consumption by Countries (2014-2019)
6.1.2 APAC Human Vaccine Value by Countries (2014-2019)
6.2 APAC Human Vaccine Consumption by Type
6.3 APAC Human Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Human Vaccine by Countries
7.1.1 Europe Human Vaccine Consumption by Countries (2014-2019)
7.1.2 Europe Human Vaccine Value by Countries (2014-2019)
7.2 Europe Human Vaccine Consumption by Type
7.3 Europe Human Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human Vaccine by Countries
8.1.1 Middle East & Africa Human Vaccine Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Human Vaccine Value by Countries (2014-2019)
8.2 Middle East & Africa Human Vaccine Consumption by Type
8.3 Middle East & Africa Human Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Vaccine Distributors
10.3 Human Vaccine Customer

11 Global Human Vaccine Market Forecast
11.1 Global Human Vaccine Consumption Forecast (2019-2024)
11.2 Global Human Vaccine Forecast by Regions
11.2.1 Global Human Vaccine Forecast by Regions (2019-2024)
11.2.2 Global Human Vaccine Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Vaccine Forecast by Type
11.8 Global Human Vaccine Forecast by Application

12 Key Players Analysis
12.1 CNBG
12.1.1 Company Details
12.1.2 Human Vaccine Product Offered
12.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 CNBG News
12.2 Changsheng Life
12.2.1 Company Details
12.2.2 Human Vaccine Product Offered
12.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Changsheng Life News
12.3 Zhifei
12.3.1 Company Details
12.3.2 Human Vaccine Product Offered
12.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Zhifei News
12.4 ChengDa Bio
12.4.1 Company Details
12.4.2 Human Vaccine Product Offered
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 ChengDa Bio News
12.5 Kangtai
12.5.1 Company Details
12.5.2 Human Vaccine Product Offered
12.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Kangtai News
12.6 SINOVAC BIOTECH
12.6.1 Company Details
12.6.2 Human Vaccine Product Offered
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 SINOVAC BIOTECH News
12.7 Hissen
12.7.1 Company Details
12.7.2 Human Vaccine Product Offered
12.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Hissen News
12.8 Walvax Biotechnology
12.8.1 Company Details
12.8.2 Human Vaccine Product Offered
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Walvax Biotechnology News
12.9 GSK
12.9.1 Company Details
12.9.2 Human Vaccine Product Offered
12.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 GSK News
12.10 SANOFI
12.10.1 Company Details
12.10.2 Human Vaccine Product Offered
12.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 SANOFI News
12.11 Rong An
12.12 NuoCheng Bio
12.13 Hualan Bio
12.14 Tiantan biological
12.15 Changchun Baike
12.16 Adimmune
12.17 Zhongyianke Biotech

13 Research Findings and Conclusion